These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7664799)

  • 21. Peptide binding to empty HLA-B27 molecules of viable human cells.
    Benjamin RJ; Madrigal JA; Parham P
    Nature; 1991 May; 351(6321):74-7. PubMed ID: 2027387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
    Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N
    J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced intracellular replication of Salmonella enteritidis in HLA-B27-expressing human monocytic cells: dependency on glutamic acid at position 45 in the B pocket of HLA-B27.
    Penttinen MA; Heiskanen KM; Mohapatra R; DeLay ML; Colbert RA; Sistonen L; Granfors K
    Arthritis Rheum; 2004 Jul; 50(7):2255-63. PubMed ID: 15248225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis.
    García-Peydró M; Martí M; López de Castro JA
    J Immunol; 1999 Aug; 163(4):2299-305. PubMed ID: 10438975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of HLA-B27-specific T cell epitopes. Antigen presentation in B*2703 is limited mostly to a subset of the antigenic determinants on B*2705.
    Villadangos JA; Galocha B; García-Hoyo R; López D; García F; López de Castro JA
    Eur J Immunol; 1994 Oct; 24(10):2548-55. PubMed ID: 7523146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The South Amerindian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA-B27.
    Yagüe J; Ramos M; Vázquez J; Marina A; Albar JP; López de Castro JA
    Tissue Antigens; 1999 Mar; 53(3):227-36. PubMed ID: 10203015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Subtypes of the HLA-B27 molecule and association with spondylarthropathies].
    Toubert A; Tieng V; Boisgérault F; Dulphy N; Tamouza R; Charron D
    Ann Med Interne (Paris); 1998 Apr; 149(3):145-8. PubMed ID: 11490536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
    Appel H; Kuon W; Kuhne M; Hülsmeyer M; Kollnberger S; Kuhlmann S; Weiss E; Zeitz M; Wucherpfennig K; Bowness P; Sieper J
    J Immunol; 2004 Dec; 173(11):6564-73. PubMed ID: 15557146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution.
    Fabian H; Huser H; Narzi D; Misselwitz R; Loll B; Ziegler A; Böckmann RA; Uchanska-Ziegler B; Naumann D
    J Mol Biol; 2008 Feb; 376(3):798-810. PubMed ID: 18178223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
    Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
    J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope.
    Nietfield W; Bauer M; Fevrier M; Maier R; Holzwarth B; Frank R; Maier B; Riviere Y; Meyerhans A
    J Immunol; 1995 Mar; 154(5):2189-97. PubMed ID: 7868892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.
    Hülsmeyer M; Welfle K; Pöhlmann T; Misselwitz R; Alexiev U; Welfle H; Saenger W; Uchanska-Ziegler B; Ziegler A
    J Mol Biol; 2005 Mar; 346(5):1367-79. PubMed ID: 15713487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence the stability of peptide - MHC complexes.
    Carreno BM; Winter CC; Taurog JD; Hansen TH; Biddison WE
    Int Immunol; 1993 Apr; 5(4):353-60. PubMed ID: 8494822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation.
    Alvarez I; Martí M; Vázquez J; Camafeita E; Ogueta S; López de Castro JA
    J Biol Chem; 2001 Dec; 276(52):48740-7. PubMed ID: 11673468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes. Implications for HLA-B27 association to spondyloarthropathy.
    López D; García-Hoyo R; López de Castro JA
    J Immunol; 1994 Jun; 152(11):5557-71. PubMed ID: 8189072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.
    Buxton SE; Benjamin RJ; Clayberger C; Parham P; Krensky AM
    J Exp Med; 1992 Mar; 175(3):809-20. PubMed ID: 1371304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism.
    Galocha B; Lamas JR; Villadangos JA; Albar JP; López de Castro JA
    Tissue Antigens; 1996 Nov; 48(5):509-18. PubMed ID: 8988533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pocket mutations of HLA-B27 show that anchor residues act cumulatively to stabilize peptide binding.
    Parker KC; Biddison WE; Coligan JE
    Biochemistry; 1994 Jun; 33(24):7736-43. PubMed ID: 8011638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presentation of cytosolically stable peptides by HLA-B27 is not dependent on the canonic interactions of N-terminal basic residues in the A pocket.
    Gómez P; Mavian C; Galocha B; García-Medel N; López de Castro JA
    J Immunol; 2009 Jan; 182(1):446-55. PubMed ID: 19109176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.
    Fruci D; Rovero P; Butler RH; Sorrentino R; Tosi R; Tanigaki N
    Immunogenetics; 1993; 38(1):41-6. PubMed ID: 8462993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.